Global Parkinson's Disease Treatments Market Growth 2018-2023

December 2018 | 161 pages | ID: G8013A1F823EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.

According to this study, over the next five years the Parkinson's Disease Treatments market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Parkinson's Disease Treatments business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson's Disease Treatments market by product type, application, key manufacturers and key regions and countries.

This study considers the Parkinson's Disease Treatments value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.

• Dopamine Agonists
• Levodopa
• Glutamate Antagonist
• Apomorphine
• COMT Inhibitors Anticholinergics
• MAO-B Inhibitors
• Other Drugs

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.

• Hospitals
• Healthcare Institutes
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• GSK
• Merck
• Novartis
• Teva
• Boehringer Ingelheim
• Impax
• Abbvie
• Valeant Pharmaceuticals
• Lundbeck
• Sun Pharma
• Wockhardt
• Acadia
• UCB

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Parkinson's Disease Treatments consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Parkinson's Disease Treatments market by identifying its various subsegments.
• Focuses on the key global Parkinson's Disease Treatments manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Parkinson's Disease Treatments with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Parkinson's Disease Treatments submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL PARKINSON'S DISEASE TREATMENTS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Parkinson's Disease Treatments Consumption 2013-2023
  2.1.2 Parkinson's Disease Treatments Consumption CAGR by Region
2.2 Parkinson's Disease Treatments Segment by Type
  2.2.1 Dopamine Agonists
  2.2.2 Levodopa
  2.2.3 Glutamate Antagonist
  2.2.4 Apomorphine
  2.2.5 COMT Inhibitors Anticholinergics
  2.2.6 MAO-B Inhibitors
  2.2.7 Other Drugs
2.3 Parkinson's Disease Treatments Consumption by Type
  2.3.1 Global Parkinson's Disease Treatments Consumption Market Share by Type (2013-2018)
  2.3.2 Global Parkinson's Disease Treatments Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Parkinson's Disease Treatments Sale Price by Type (2013-2018)
2.4 Parkinson's Disease Treatments Segment by Application
  2.4.1 Hospitals
  2.4.2 Healthcare Institutes
  2.4.3 Others
2.5 Parkinson's Disease Treatments Consumption by Application
  2.5.1 Global Parkinson's Disease Treatments Consumption Market Share by Application (2013-2018)
  2.5.2 Global Parkinson's Disease Treatments Value and Market Share by Application (2013-2018)
  2.5.3 Global Parkinson's Disease Treatments Sale Price by Application (2013-2018)

3 GLOBAL PARKINSON'S DISEASE TREATMENTS BY PLAYERS

3.1 Global Parkinson's Disease Treatments Sales Market Share by Players
  3.1.1 Global Parkinson's Disease Treatments Sales by Players (2016-2018)
  3.1.2 Global Parkinson's Disease Treatments Sales Market Share by Players (2016-2018)
3.2 Global Parkinson's Disease Treatments Revenue Market Share by Players
  3.2.1 Global Parkinson's Disease Treatments Revenue by Players (2016-2018)
  3.2.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2016-2018)
3.3 Global Parkinson's Disease Treatments Sale Price by Players
3.4 Global Parkinson's Disease Treatments Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Parkinson's Disease Treatments Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Parkinson's Disease Treatments Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PARKINSON'S DISEASE TREATMENTS BY REGIONS

4.1 Parkinson's Disease Treatments by Regions
  4.1.1 Global Parkinson's Disease Treatments Consumption by Regions
  4.1.2 Global Parkinson's Disease Treatments Value by Regions
4.2 Americas Parkinson's Disease Treatments Consumption Growth
4.3 APAC Parkinson's Disease Treatments Consumption Growth
4.4 Europe Parkinson's Disease Treatments Consumption Growth
4.5 Middle East & Africa Parkinson's Disease Treatments Consumption Growth

5 AMERICAS

5.1 Americas Parkinson's Disease Treatments Consumption by Countries
  5.1.1 Americas Parkinson's Disease Treatments Consumption by Countries (2013-2018)
  5.1.2 Americas Parkinson's Disease Treatments Value by Countries (2013-2018)
5.2 Americas Parkinson's Disease Treatments Consumption by Type
5.3 Americas Parkinson's Disease Treatments Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Parkinson's Disease Treatments Consumption by Countries
  6.1.1 APAC Parkinson's Disease Treatments Consumption by Countries (2013-2018)
  6.1.2 APAC Parkinson's Disease Treatments Value by Countries (2013-2018)
6.2 APAC Parkinson's Disease Treatments Consumption by Type
6.3 APAC Parkinson's Disease Treatments Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Parkinson's Disease Treatments by Countries
  7.1.1 Europe Parkinson's Disease Treatments Consumption by Countries (2013-2018)
  7.1.2 Europe Parkinson's Disease Treatments Value by Countries (2013-2018)
7.2 Europe Parkinson's Disease Treatments Consumption by Type
7.3 Europe Parkinson's Disease Treatments Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Parkinson's Disease Treatments by Countries
  8.1.1 Middle East & Africa Parkinson's Disease Treatments Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Parkinson's Disease Treatments Value by Countries (2013-2018)
8.2 Middle East & Africa Parkinson's Disease Treatments Consumption by Type
8.3 Middle East & Africa Parkinson's Disease Treatments Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Parkinson's Disease Treatments Distributors
10.3 Parkinson's Disease Treatments Customer

11 GLOBAL PARKINSON'S DISEASE TREATMENTS MARKET FORECAST

11.1 Global Parkinson's Disease Treatments Consumption Forecast (2018-2023)
11.2 Global Parkinson's Disease Treatments Forecast by Regions
  11.2.1 Global Parkinson's Disease Treatments Forecast by Regions (2018-2023)
  11.2.2 Global Parkinson's Disease Treatments Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Parkinson's Disease Treatments Forecast by Type
11.8 Global Parkinson's Disease Treatments Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 GSK
  12.1.1 Company Details
  12.1.2 Parkinson's Disease Treatments Product Offered
  12.1.3 GSK Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 GSK News
12.2 Merck
  12.2.1 Company Details
  12.2.2 Parkinson's Disease Treatments Product Offered
  12.2.3 Merck Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Merck News
12.3 Novartis
  12.3.1 Company Details
  12.3.2 Parkinson's Disease Treatments Product Offered
  12.3.3 Novartis Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Novartis News
12.4 Teva
  12.4.1 Company Details
  12.4.2 Parkinson's Disease Treatments Product Offered
  12.4.3 Teva Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Teva News
12.5 Boehringer Ingelheim
  12.5.1 Company Details
  12.5.2 Parkinson's Disease Treatments Product Offered
  12.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Boehringer Ingelheim News
12.6 Impax
  12.6.1 Company Details
  12.6.2 Parkinson's Disease Treatments Product Offered
  12.6.3 Impax Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Impax News
12.7 Abbvie
  12.7.1 Company Details
  12.7.2 Parkinson's Disease Treatments Product Offered
  12.7.3 Abbvie Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Abbvie News
12.8 Valeant Pharmaceuticals
  12.8.1 Company Details
  12.8.2 Parkinson's Disease Treatments Product Offered
  12.8.3 Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Valeant Pharmaceuticals News
12.9 Lundbeck
  12.9.1 Company Details
  12.9.2 Parkinson's Disease Treatments Product Offered
  12.9.3 Lundbeck Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Lundbeck News
12.10 Sun Pharma
  12.10.1 Company Details
  12.10.2 Parkinson's Disease Treatments Product Offered
  12.10.3 Sun Pharma Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Sun Pharma News
12.11 Wockhardt
12.12 Acadia
12.13 UCB

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson's Disease Treatments
Table Product Specifications of Parkinson's Disease Treatments
Figure Parkinson's Disease Treatments Report Years Considered
Figure Market Research Methodology
Figure Global Parkinson's Disease Treatments Consumption Growth Rate 2013-2023 (K Patches)
Figure Global Parkinson's Disease Treatments Value Growth Rate 2013-2023 ($ Millions)
Table Parkinson's Disease Treatments Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Dopamine Agonists
Table Major Players of Dopamine Agonists
Figure Product Picture of Levodopa
Table Major Players of Levodopa
Figure Product Picture of Glutamate Antagonist
Table Major Players of Glutamate Antagonist
Figure Product Picture of Apomorphine
Table Major Players of Apomorphine
Figure Product Picture of COMT Inhibitors Anticholinergics
Table Major Players of COMT Inhibitors Anticholinergics
Figure Product Picture of MAO-B Inhibitors
Table Major Players of MAO-B Inhibitors
Figure Product Picture of Other Drugs
Table Major Players of Other Drugs
Table Global Consumption Sales by Type (2013-2018)
Table Global Parkinson's Disease Treatments Consumption Market Share by Type (2013-2018)
Figure Global Parkinson's Disease Treatments Consumption Market Share by Type (2013-2018)
Table Global Parkinson's Disease Treatments Revenue by Type (2013-2018) ($ million)
Table Global Parkinson's Disease Treatments Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Parkinson's Disease Treatments Value Market Share by Type (2013-2018)
Table Global Parkinson's Disease Treatments Sale Price by Type (2013-2018)
Figure Parkinson's Disease Treatments Consumed in Hospitals
Figure Global Parkinson's Disease Treatments Market: Hospitals (2013-2018) (K Patches)
Figure Global Parkinson's Disease Treatments Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Parkinson's Disease Treatments Consumed in Healthcare Institutes
Figure Global Parkinson's Disease Treatments Market: Healthcare Institutes (2013-2018) (K Patches)
Figure Global Parkinson's Disease Treatments Market: Healthcare Institutes (2013-2018) ($ Millions)
Figure Global Healthcare Institutes YoY Growth ($ Millions)
Figure Parkinson's Disease Treatments Consumed in Others
Figure Global Parkinson's Disease Treatments Market: Others (2013-2018) (K Patches)
Figure Global Parkinson's Disease Treatments Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Parkinson's Disease Treatments Consumption Market Share by Application (2013-2018)
Figure Global Parkinson's Disease Treatments Consumption Market Share by Application (2013-2018)
Table Global Parkinson's Disease Treatments Value by Application (2013-2018)
Table Global Parkinson's Disease Treatments Value Market Share by Application (2013-2018)
Figure Global Parkinson's Disease Treatments Value Market Share by Application (2013-2018)
Table Global Parkinson's Disease Treatments Sale Price by Application (2013-2018)
Table Global Parkinson's Disease Treatments Sales by Players (2016-2018) (K Patches)
Table Global Parkinson's Disease Treatments Sales Market Share by Players (2016-2018)
Figure Global Parkinson's Disease Treatments Sales Market Share by Players in 2016
Figure Global Parkinson's Disease Treatments Sales Market Share by Players in 2017
Table Global Parkinson's Disease Treatments Revenue by Players (2016-2018) ($ Millions)
Table Global Parkinson's Disease Treatments Revenue Market Share by Players (2016-2018)
Figure Global Parkinson's Disease Treatments Revenue Market Share by Players in 2016
Figure Global Parkinson's Disease Treatments Revenue Market Share by Players in 2017
Table Global Parkinson's Disease Treatments Sale Price by Players (2016-2018)
Figure Global Parkinson's Disease Treatments Sale Price by Players in 2017
Table Global Parkinson's Disease Treatments Manufacturing Base Distribution and Sales Area by Players
Table Players Parkinson's Disease Treatments Products Offered
Table Parkinson's Disease Treatments Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Parkinson's Disease Treatments Consumption by Regions 2013-2018 (K Patches)
Table Global Parkinson's Disease Treatments Consumption Market Share by Regions 2013-2018
Figure Global Parkinson's Disease Treatments Consumption Market Share by Regions 2013-2018
Table Global Parkinson's Disease Treatments Value by Regions 2013-2018 ($ Millions)
Table Global Parkinson's Disease Treatments Value Market Share by Regions 2013-2018
Figure Global Parkinson's Disease Treatments Value Market Share by Regions 2013-2018
Figure Americas Parkinson's Disease Treatments Consumption 2013-2018 (K Patches)
Figure Americas Parkinson's Disease Treatments Value 2013-2018 ($ Millions)
Figure APAC Parkinson's Disease Treatments Consumption 2013-2018 (K Patches)
Figure APAC Parkinson's Disease Treatments Value 2013-2018 ($ Millions)
Figure Europe Parkinson's Disease Treatments Consumption 2013-2018 (K Patches)
Figure Europe Parkinson's Disease Treatments Value 2013-2018 ($ Millions)
Figure Middle East & Africa Parkinson's Disease Treatments Consumption 2013-2018 (K Patches)
Figure Middle East & Africa Parkinson's Disease Treatments Value 2013-2018 ($ Millions)
Table Americas Parkinson's Disease Treatments Consumption by Countries (2013-2018) (K Patches)
Table Americas Parkinson's Disease Treatments Consumption Market Share by Countries (2013-2018)
Figure Americas Parkinson's Disease Treatments Consumption Market Share by Countries in 2017
Table Americas Parkinson's Disease Treatments Value by Countries (2013-2018) ($ Millions)
Table Americas Parkinson's Disease Treatments Value Market Share by Countries (2013-2018)
Figure Americas Parkinson's Disease Treatments Value Market Share by Countries in 2017
Table Americas Parkinson's Disease Treatments Consumption by Type (2013-2018) (K Patches)
Table Americas Parkinson's Disease Treatments Consumption Market Share by Type (2013-2018)
Figure Americas Parkinson's Disease Treatments Consumption Market Share by Type in 2017
Table Americas Parkinson's Disease Treatments Consumption by Application (2013-2018) (K Patches)
Table Americas Parkinson's Disease Treatments Consumption Market Share by Application (2013-2018)
Figure Americas Parkinson's Disease Treatments Consumption Market Share by Application in 2017
Figure United States Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure United States Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Canada Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Canada Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Mexico Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Mexico Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Table APAC Parkinson's Disease Treatments Consumption by Countries (2013-2018) (K Patches)
Table APAC Parkinson's Disease Treatments Consumption Market Share by Countries (2013-2018)
Figure APAC Parkinson's Disease Treatments Consumption Market Share by Countries in 2017
Table APAC Parkinson's Disease Treatments Value by Countries (2013-2018) ($ Millions)
Table APAC Parkinson's Disease Treatments Value Market Share by Countries (2013-2018)
Figure APAC Parkinson's Disease Treatments Value Market Share by Countries in 2017
Table APAC Parkinson's Disease Treatments Consumption by Type (2013-2018) (K Patches)
Table APAC Parkinson's Disease Treatments Consumption Market Share by Type (2013-2018)
Figure APAC Parkinson's Disease Treatments Consumption Market Share by Type in 2017
Table APAC Parkinson's Disease Treatments Consumption by Application (2013-2018) (K Patches)
Table APAC Parkinson's Disease Treatments Consumption Market Share by Application (2013-2018)
Figure APAC Parkinson's Disease Treatments Consumption Market Share by Application in 2017
Figure China Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure China Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Japan Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Japan Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Korea Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Korea Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Southeast Asia Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure India Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure India Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Australia Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Australia Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Table Europe Parkinson's Disease Treatments Consumption by Countries (2013-2018) (K Patches)
Table Europe Parkinson's Disease Treatments Consumption Market Share by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatments Consumption Market Share by Countries in 2017
Table Europe Parkinson's Disease Treatments Value by Countries (2013-2018) ($ Millions)
Table Europe Parkinson's Disease Treatments Value Market Share by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatments Value Market Share by Countries in 2017
Table Europe Parkinson's Disease Treatments Consumption by Type (2013-2018) (K Patches)
Table Europe Parkinson's Disease Treatments Consumption Market Share by Type (2013-2018)
Figure Europe Parkinson's Disease Treatments Consumption Market Share by Type in 2017
Table Europe Parkinson's Disease Treatments Consumption by Application (2013-2018) (K Patches)
Table Europe Parkinson's Disease Treatments Consumption Market Share by Application (2013-2018)
Figure Europe Parkinson's Disease Treatments Consumption Market Share by Application in 2017
Figure Germany Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Germany Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure France Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure France Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure UK Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure UK Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Italy Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Italy Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Russia Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Russia Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Spain Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Spain Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Parkinson's Disease Treatments Consumption by Countries (2013-2018) (K Patches)
Table Middle East & Africa Parkinson's Disease Treatments Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinson's Disease Treatments Consumption Market Share by Countries in 2017
Table Middle East & Africa Parkinson's Disease Treatments Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Parkinson's Disease Treatments Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinson's Disease Treatments Value Market Share by Countries in 2017
Table Middle East & Africa Parkinson's Disease Treatments Consumption by Type (2013-2018) (K Patches)
Table Middle East & Africa Parkinson's Disease Treatments Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Parkinson's Disease Treatments Consumption Market Share by Type in 2017
Table Middle East & Africa Parkinson's Disease Treatments Consumption by Application (2013-2018) (K Patches)
Table Middle East & Africa Parkinson's Disease Treatments Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Parkinson's Disease Treatments Consumption Market Share by Application in 2017
Figure Egypt Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Egypt Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure South Africa Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure South Africa Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Israel Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Israel Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure Turkey Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure Turkey Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Parkinson's Disease Treatments Consumption Growth 2013-2018 (K Patches)
Figure GCC Countries Parkinson's Disease Treatments Value Growth 2013-2018 ($ Millions)
Table Parkinson's Disease Treatments Distributors List
Table Parkinson's Disease Treatments Customer List
Figure Global Parkinson's Disease Treatments Consumption Growth Rate Forecast (2018-2023) (K Patches)
Figure Global Parkinson's Disease Treatments Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Parkinson's Disease Treatments Consumption Forecast by Countries (2018-2023) (K Patches)
Table Global Parkinson's Disease Treatments Consumption Market Forecast by Regions
Table Global Parkinson's Disease Treatments Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Parkinson's Disease Treatments Value Market Share Forecast by Regions
Figure Americas Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Americas Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure APAC Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure APAC Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Europe Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Europe Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Middle East & Africa Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Middle East & Africa Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure United States Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure United States Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Canada Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Canada Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Mexico Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Mexico Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Brazil Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Brazil Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure China Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure China Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Japan Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Japan Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Korea Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Korea Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Southeast Asia Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Southeast Asia Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure India Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure India Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Australia Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Australia Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Germany Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Germany Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure France Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure France Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure UK Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure UK Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Italy Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Italy Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Russia Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Russia Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Spain Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Spain Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Egypt Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Egypt Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure South Africa Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure South Africa Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Israel Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Israel Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure Turkey Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure Turkey Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Figure GCC Countries Parkinson's Disease Treatments Consumption 2018-2023 (K Patches)
Figure GCC Countries Parkinson's Disease Treatments Value 2018-2023 ($ Millions)
Table Global Parkinson's Disease Treatments Consumption Forecast by Type (2018-2023) (K Patches)
Table Global Parkinson's Disease Treatments Consumption Market Share Forecast by Type (2018-2023)
Table Global Parkinson's Disease Treatments Value Forecast by Type (2018-2023) ($ Millions)
Table Global Parkinson's Disease Treatments Value Market Share Forecast by Type (2018-2023)
Table Global Parkinson's Disease Treatments Consumption Forecast by Application (2018-2023) (K Patches)
Table Global Parkinson's Disease Treatments Consumption Market Share Forecast by Application (2018-2023)
Table Global Parkinson's Disease Treatments Value Forecast by Application (2018-2023) ($ Millions)
Table Global Parkinson's Disease Treatments Value Market Share Forecast by Application (2018-2023)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Parkinson's Disease Treatments Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Parkinson's Disease Treatments Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Parkinson's Disease Treatments Market Share (2016-2018)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Parkinson's Disease Treatments Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Parkinson's Disease Treatments Market Share (2016-2018)
Table Impax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Impax Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Impax Parkinson's Disease Treatments Market Share (2016-2018)
Table Abbvie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbvie Parkinson's Disease Treatments Market Share (2016-2018)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals Parkinson's Disease Treatments Market Share (2016-2018)
Table Lundbeck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lundbeck Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lundbeck Parkinson's Disease Treatments Market Share (2016-2018)
Table Sun Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharma Parkinson's Disease Treatments Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharma Parkinson's Disease Treatments Market Share (2016-2018)
Table Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acadia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors